Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-05-15 Option Award |
2020-05-19 4:05 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
140 | $5.86 | 81,706 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 4:05 pm |
N/A 2030-05-15 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
140 | $0 | 81,706 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-04 4:09 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
133 | $6.17 | 81,559 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-04 4:09 pm |
N/A 2030-04-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer |
133 | $0 | 81,559 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-04 4:09 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
319 | $6.17 | 9,435 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-04 4:09 pm |
N/A 2030-04-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer |
319 | $0 | 9,435 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-04 4:08 pm |
N/A N/A |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS Chief Financial Officer |
53 | $6.17 | 4,982 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-04 4:08 pm |
N/A 2030-04-30 |
LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS Chief Financial Officer |
53 | $0 | 4,982 (Direct) |
View |